ITRM
Price
$1.02
Change
-$0.01 (-0.97%)
Updated
Jun 26 closing price
Capitalization
40.8M
42 days until earnings call
TARA
Price
$2.98
Change
-$0.00 (-0.00%)
Updated
Jun 27, 10:38 AM (EDT)
Capitalization
114.97M
45 days until earnings call
Interact to see
Advertisement

ITRM vs TARA

Header iconITRM vs TARA Comparison
Open Charts ITRM vs TARABanner chart's image
Iterum Therapeutics
Price$1.02
Change-$0.01 (-0.97%)
Volume$500.85K
Capitalization40.8M
Protara Therapeutics
Price$2.98
Change-$0.00 (-0.00%)
Volume$160
Capitalization114.97M
ITRM vs TARA Comparison Chart in %
Loading...
ITRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TARA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ITRM vs. TARA commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ITRM is a Buy and TARA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (ITRM: $1.02 vs. TARA: $2.98)
Brand notoriety: ITRM and TARA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ITRM: 83% vs. TARA: 76%
Market capitalization -- ITRM: $40.8M vs. TARA: $114.97M
ITRM [@Biotechnology] is valued at $40.8M. TARA’s [@Biotechnology] market capitalization is $114.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ITRM’s FA Score shows that 1 FA rating(s) are green whileTARA’s FA Score has 1 green FA rating(s).

  • ITRM’s FA Score: 1 green, 4 red.
  • TARA’s FA Score: 1 green, 4 red.
According to our system of comparison, both ITRM and TARA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ITRM’s TA Score shows that 4 TA indicator(s) are bullish while TARA’s TA Score has 2 bullish TA indicator(s).

  • ITRM’s TA Score: 4 bullish, 4 bearish.
  • TARA’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, ITRM is a better buy in the short-term than TARA.

Price Growth

ITRM (@Biotechnology) experienced а +2.31% price change this week, while TARA (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.59%. For the same industry, the average monthly price growth was +34.25%, and the average quarterly price growth was +14.95%.

Reported Earning Dates

ITRM is expected to report earnings on Aug 08, 2025.

TARA is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+3.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TARA($115M) has a higher market cap than ITRM($40.8M). ITRM (-42.373) and TARA (-43.561) have similar YTD gains . ITRM has higher annual earnings (EBITDA): -19.12M vs. TARA (-51.1M). TARA has more cash in the bank: 124M vs. ITRM (12.7M). TARA has less debt than ITRM: TARA (4.23M) vs ITRM (32M). ITRM (0) and TARA (0) have equivalent revenues.
ITRMTARAITRM / TARA
Capitalization40.8M115M35%
EBITDA-19.12M-51.1M37%
Gain YTD-42.373-43.56197%
P/E RatioN/AN/A-
Revenue00-
Total Cash12.7M124M10%
Total Debt32M4.23M757%
FUNDAMENTALS RATINGS
ITRM vs TARA: Fundamental Ratings
ITRM
TARA
OUTLOOK RATING
1..100
658
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
15
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
6364
P/E GROWTH RATING
1..100
2100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TARA's Valuation (15) in the null industry is significantly better than the same rating for ITRM (87) in the Biotechnology industry. This means that TARA’s stock grew significantly faster than ITRM’s over the last 12 months.

TARA's Profit vs Risk Rating (100) in the null industry is in the same range as ITRM (100) in the Biotechnology industry. This means that TARA’s stock grew similarly to ITRM’s over the last 12 months.

TARA's SMR Rating (97) in the null industry is in the same range as ITRM (100) in the Biotechnology industry. This means that TARA’s stock grew similarly to ITRM’s over the last 12 months.

ITRM's Price Growth Rating (63) in the Biotechnology industry is in the same range as TARA (64) in the null industry. This means that ITRM’s stock grew similarly to TARA’s over the last 12 months.

ITRM's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for TARA (100) in the null industry. This means that ITRM’s stock grew significantly faster than TARA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ITRMTARA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 18 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ITRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TARA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LNC34.521.59
+4.83%
Lincoln National Corp
ACNB42.971.21
+2.90%
ACNB Corp
MMI30.370.46
+1.54%
Marcus & Millichap
DSWL2.460.01
+0.61%
Deswell Industries
CSX32.570.08
+0.25%
CSX Corp

ITRM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ITRM has been loosely correlated with PLRX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ITRM jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITRM
1D Price
Change %
ITRM100%
-0.97%
PLRX - ITRM
42%
Loosely correlated
-5.80%
ORMP - ITRM
34%
Loosely correlated
-0.46%
TARA - ITRM
33%
Poorly correlated
-2.61%
ACRS - ITRM
33%
Poorly correlated
-4.29%
RNAZ - ITRM
30%
Poorly correlated
+7.18%
More